Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3213_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
12.10.2026
Размер:
3 Мб
Скачать
☆
Источник KingMed.info
391
Weijs B., de Vos C.B., Tieleman R.G. et al. The occurrence of cardiovascular disease during 5-year
follow-up in patients with idiopathic atrial fibrillation // Europace.
2013. Vol. 15, N. 1. P. 18-23.
Weimar C., Bilbilis K., Rekowski J. et al. Safety of simultaneous coronary artery bypass grafting and
carotid endarterectomy versus isolated coronary artery bypass grafting // Stroke. 2017. Vol. 10. P.
2769-2775.
Wemmelund H., Hogh A., Hundborg H.H. et al. Preadmission use of renin-angiotensin blockers and
rupture of abdominal aortic aneurysm: a nationwide, population-
based study // Pharmacoepidemiol. Drug Saf. 2016. Vol. 25, N. 2. P. 141-150.
Westin G.G., Armstrong E.J., Bang H. et al. Association between statin medications and mortality, major
adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia // J.
Am. Coll. Cardiol. 2014. Vol. 63, N. 7.
P. 682-690.
Westover M.B., Bianchi M.T., Eckman M.H., Greenberg S.M. Should statins be avoided after intracerebral
hemorrhage // Arch. Neurol. 2011. Vol. 68, N. 5. P. 573-579. White H.D. Thrombolytic therapy in the
elderly // Lancet. 2000. Vol. 356. P. 2028-
2030.
Wieck A., Haddad P. Hyperprolactinaemia caused by antipsychotic drugs: this common side effect
needs more attention // BMJ. 2002. Vol. 324, N. 7332. P. 250-252.
Wiesel J., Abraham S., Messineo F.C. Screening for asymptomatic atrial fibrillation while monitoring the
blood pressure at home: trial of regular versus irregular pulse for prevention of stroke // Am. J. Cardiol.
2013. Vol. 111, N. 11. P. 1598-1601.
Wijeysundera D.N., Bender J.S., Beattie W.S. Alpha-2 adrenergic agonists for the prevention of cardiac
complications among patients undergoing surgery // Cochrane
Database Syst. Rev. 2009. Vol. 4.
Wilchesky M., Ernst P., Brophy J.M. et al. Bronchodilator use and the risk of arrhythmia in COPD
bronchodilators and arrhythmia risk: Part 1: Saskatchewan cohort study // Chest. 2012. Vol. 142, N. 2. P.
298-304.
Wilchesky M., Ernst P., Brophy J.M. et al. Bronchodilator use and the risk of arrhythmia in COPD. Risk in
COPD. Part 2: reassessment in the larger Quebec cohort // Chest. 2012. Vol. 142, N. 2. P. 305-311.
Williams J.S., Egede L.E. The Association between multimorbidity and quality of
life, health status and functional disability // Am. J. Med. Sci. 2016. Vol. 352, N. 1. P. 45-52.
Wilson L.M., Rebholz C.M., Jirru E. et al. Benefits and harms of osteoporosis medications in patients
with chronic kidney disease: a systematic review and meta-
analysis // Ann. Intern. Med. 2017. Vol. 166. P. 649-658.
Wilton S.B., Fundytus A., Ghali W.A. et al. Meta-analysis of the effectiveness and safety of catheter
ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction // Am. J.
Cardiol. 2010. Vol. 106. P. 1284-1291.
Источник KingMed.info
392
Winthrop K.L., Silverfield J., Racewicz A. et al. The effect of tofacitinib on pneumococcal and influenza
vaccine responses in rheumatoid arthritis // Ann. Rheum. Dis.
2016. Vol. 75, N. 4. P. 687-695.
Witte K.K., Drozd M., Walker A.M.N. et al. Mortality reduction associated with β-adrenoceptor inhibition
in chronic heart failure is greater in patients with diabetes //
Diabetes Care. 2018. Vol. 41, N. 1. P. 136-142.
Wium-Andersen I.K., Wium-Andersen M.K., Jorgensen M.B., Osler M. Antiinflammatory treatment and
risk of depression in 91 842 patients with acute coronary syndrome and 91 860 individuals without
acute coronary syndrome in Denmark // Int.
J. Cardiol. 2017. Vol. 246. P. 1-6.
WolffJ.L., Starfield B., Anderson G. Prevalence, expenditures, and complications of multiple chronic
conditions in the elderly // Arch. Intern. Med. 2002. Vol. 162,
N. 20. P. 2269-2276.
Wong A.K., Symon R., Alzadjali M.A. et al. The effect of metformin on insulin resistance and exercise
parameters in patients with heart failure // Eur. J. Heart Fail. 2012. Vol. 14, N. 11. P. 1303-1310.
Wong C.X., Odutayo A., Emdin C.A. et al. Meta-analysis of anticoagulation use, stroke,
thromboembolism, bleeding, and mortality in patients with atrial fibrillation on dialysis // Am. J.
Cardiol. 2016. Vol. 117, N. 12. P. 1934-1941.
Wong C.Y., Chaudhry S.I., Desai M.M. et al. Trends in comorbidity, disability, and polypharmacy in heart
failure // Am. J. Med. 2011. Vol. 124, N. 2. P. 136-143.
Wongcharoen W., Ruttanaphol A., Gunaparn S., Phrommintikul A. Ivabradine reduced ventricular rate in
patients with non-paroxysmal atrial fibrillation. Int J Card. 2016;224:252-255.
Wongcharoen W., Lin Y.J., Chang S.L. et al. History of hyperthyroidism and long-term outcome of
catheter ablation of drug-refractory atrial fibrillation. Heart Rhythm. 2015;12(9):1956-62.
Woon V.C., Lim K.H. Acute myocardial infarction in the elderly - the differences compared with the
young // Singapore Med. J. 2003. Vol. 44, N. 8. P. 414-418.
Wright A.P., Adusumalli S., Corey K.E. Statin therapy in patients with cirrhosis //
Frontline Gastroenterol. 2015. Vol. 6, N. 4. P. 255-261.
Wrigley P., Khoury J., Eckerle B. et al. Prevalence of positive troponin and echocardiogram findings and
association with mortality in acute ischemic stroke // Stroke.
2017. Vol. 5. P. 1226-1232.
Wu A.H., Levy W.C., Welch K.B. et al. Association between bilirubin and mode of death in severe systolic
heart failure // Am. J. Cardiol. 2013. Vol. 111, N. 8. P. 1192- 1197.
Wu C., Chang C., Kor C. et al. Hydroxychloroquine use and risk of CKD in patients with rheumatoid
arthritis // Clin. J. Am. Soc. Nephrol. 2018. Vol. 5. P. 702-709.
Источник KingMed.info
393
Wu C.S., Tsai Y.T., Tsai H.J. Antipsychotic drugs and the risk of ventricular arrhythmia and/or sudden
cardiac death: anation-wide case-crossover study // J. Am. Heart Assoc. 2015. Vol. 4, N. 2. Article ID
e001568.
Wu H., Huang J., Lin H. et al. Comparative effectiveness of renin-angiotensin system blockers and other
antihypertensive drugs in patients with diabetes: systematic review and Bayesian network meta-analysis
// BMJ. 2013. Vol. 347. Article ID f6008.
Wu M., Huang Z., Xie H. et al. Nicorandil in patients with acute myocardial infarction undergoing
primary percutaneous coronary intervention: a systematic review and meta-analysis // PLoS One. 2013.
Vol. 10. Article ID e78231.
Xie C., Hu J., Motloch L.J., Karam B.S. et al. The classically cardioprotective agent diazoxide elicits
arrhythmias in type 2 diabetes mellitus // J. Am. Coll. Cardiol. 2015.
Vol. 66, N. 10. P. 1144-1156.
Xie X., Liu Y., Perkovic V. et al. Renin-angiotensin system inhibitors and kidney and cardiovascular
outcomes in patients with CKD: aBayesian network meta-analysis of randomized clinical trials // Am. J.
Kidney Dis. 2016. Vol. 67, N. 5. P. 728-741.
Xie Y., Bowe B., Li T. et al. Proton pump inhibitors and risk of incident CKD and progression to ESRD //
J. Am. Soc. Nephrol. 2016. Vol. 27. P. 3153-3163.
Xu Q., Guan Y.Q., Zhang D., Su G.H. The effects of statin on atrial fibrillation: a meta-analysis of
published data from randomized controlled trials // Curr. Med. Res.
Opin. 2011. Vol. 27, N. 9. P. 1771-1779.
Xu HB, Wang HD, Li CH, et al. Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in
cirrhotic patients: a systematic review and meta-analysis. Genet Mol Res. 2015;14(3):7490-501.
Yamamoto T., Moriwaki Y., Takahashi S. et al. Effect of losartan potassium, an angiotensin II receptor
antagonist, on renal excretion of oxypurinol and purine bases //
J. Rheumatol. 2000. Vol. 27. P. 2232-2236.
Yang W., Cai X., Han X. et al. DPP-4 inhibitors and risk of infections: a meta-analysis of randomized
controlled trials // Diabetes Metab. Res. Rev. 2016. Vol. 32, N. 4. P. 391-404.
Yanovski S.Z., Yanovski J.A. Long-term drug treatment for obesity: asystematic and clinical review //
JAMA. 2014. Vol. 311, N. 1. P. 74-86.
Yonkers K.A., Gilstad-Hayden K., Forray A., Lipkind H.S. Association of panic disorder, generalized
anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes
// JAMA Psychiatry. 2017. Vol. 74, N. 11.
P. 1145-1152.
Yoshida K., Furuta K., Adachi K. et al. Effects of anti-hypertensive drugs on esophageal body contraction
// World J. Gastroenterol. 2010. Vol. 16, N. 8. P. 987-991.
Younossi ZM, Henry L, Ong JP, et al. Systematic review with meta-analysis: extrahepatic manifestations
in chronic hepatitis C virus-infected patients in East Asia. Aliment Pharmacol Ther. 2019;49:644-653.
Yu E.W., Bauer S.R., Bain P.A. et al. Proton pump inhibitors and risk of fractures: a meta-analysis of 11
international studies // Am. J. Med. 2011. Vol. 124, N. 6.
Источник KingMed.info
394
P. 519-526.
Yu J., Mehran R., Dangas G.D. et al. Safety and efficacy of highversus low-dose aspirin after primary
percutaneous coronary intervention in ST-segment elevation myo-
cardial infarction // JACC Cardiovasc. Interv. 2012. Vol. 5. P. 1231-1238.
Yu S., Fu A.Z., Qiu Y. et al. Disease burden of urinary tract infections among type 2 diabetes mellitus
patients in the US // J. Diabet. Complicat. 2014. Vol. 28, N. 5.
P. 621-626.
Yu X.J., Yang X., Feng L. et al. Association between Helicobacter pylori infection and angiographically
demonstrated coronary artery disease: a meta-analysis // Exp.
Ther. Med. 2017. Vol. 13, N. 2. P. 787-793.
Yu Z.H., Jiang H.Y., Shao L. et al. Use of antipsychotics and risk of myocar-dial infarction: a systematic
review and meta-analysis // Br. J. Clin. Pharmacol. 2016.
Vol. 82, N. 3. P. 624-632.
Yu E.W., Bauer S.R., Bain P.A. et al. Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11
International Studies // Am. J. Med. 2011. Vol. 124, N. 6.
P. 519-526.
Yuan C., Zhou L., Cheng J. et al. Statins as potential therapeutic drug for asthma? // Respir. Res. 2012.
Vol. 13. P. 108.
Yuan J.Q., Tsoi K.K., Yang M. et al. Systematic review with network meta-analysis: comparative
effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity //
Aliment. Pharmacol. Ther. 2016. Vol. 43, N. 12. P. 1262-1275.
Yusuke K., Yasuji A., Kenji I. et al. Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-
treated hepatitis C patients // Am. J. Med. 2010. Vol. 123,
N. 10. P. 951-956.
Zafrir B., Lund L., Laroche C. et al. Prognostic implications of atrial fibrillation in heart failure with
reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European
Society of Cardiology Heart Failure Long-Term
Registry // Eur. Heart J. 2018. Vol. 48. P. 4277-4284.
Zardi E.M., Abbate A., Zardi D. et al. Cirrhotic cardiomyopathy // J. Am. Coll. Cardiol. 2010. Vol. 56, N. 7.
P. 539-549.
Zarek J., Koren G. The fetal safety of statins: a systematic review and meta-analy-
sis // J. Obstet. Gynaecol. Can. 2014. Vol. 36, N. 6. P. 506-509.
Zeller M. et al. Metformin and contrast-induced acute kidney injury in diabetic patients treated with
primary percutaneous coronary intervention for ST segment elevation myocardial infarction // Int. J.
Cardiol. 2016. Vol. 220. P. 137-142.
Zhang D., Shen X., Qi X. et al. Resting heart rate and all-cause and cardiovascular mortality in the
general population: a meta-analysis // CMAJ. 2016. Vol. 188, N. 3. P. E53-E63.
Источник KingMed.info
395
Zhang D., Wang W., Li F. Association between resting heart rate and coronary artery disease, stroke,
sudden death and noncardiovascular diseases: a meta-analysis //
CMAJ. 2016. Vol. 188, N. 15. P. E384-E392.
Zhang J., Xie F., Yun H. et al. Comparative effects of biologics on cardiovascular risk among older
patients with rheumatoid arthritis // Ann. Rheum. Dis. 2016. Vol. 75,
N. 10. P. 1813-1818.
Zhang M., Holman C.D., Price S.D. et al. Comorbidity and repeat admission to hospital for adverse drug
reactions in older adults: retrospective cohort study // BMJ.
2009. Vol. 338. Article ID a2752.
Zhang M., Sara J.D.S., Matsuzawa Y. et al. Clinical outcomes of patients with hypothyroidism
undergoing percutaneous coronary intervention // Eur. Heart J. 2016.
Vol. 37, N. 26. P. 2055-2065.
Zhang X., Zhao Q. Effects of dipeptidyl peptidase-4 inhibitors on blood pressure in patients with type 2
diabetes: a systematic review and meta-analysis // J. Hypertens.
2016. Vol. 34, N. 2. P. 167-175.
Zhang Y., Li S., He L. et al. Combination therapy of fenofibrate and ursodeoxycho-lic acid in patients
with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis //
Drug Des. Devel. Ther. 2015. Vol. 9. P. 2757-2766.
Zhang Y., Neogi T., Chen C. et al. Low-dose aspirin use and recurrent gout
attacks // Ann. Rheum. Dis. 2014. Vol. 73, N. 2. P. 385-390.
Zhang Z., Zhang X., Korantzopoulos P. et al. Thiazolidinedione use and atrial fibrillation in diabetic
patients: a meta-analysis // BMC Cardiovasc. Disord. 2017.
Vol. 17, N. 1. P. 96.
Zhao X., Huang K., Zheng M. et al. Effect of liraglutide on blood pressure: a meta-analysis of liraglutide
randomized controlled trials // BMC Endocr. Disord. 2019.
Vol. 19, N. 1. P. 4.
Zhao Y.Y., Weir M.A., Manno M. et al. New fibrate use and acute renal outcomes
in elderly adults // Ann. Intern. Med. 2012. Vol. 156, N. 8. P. 560-569.
Zhu W., Guo L., Hong K. Relationship between smoking and adverse outcomes in patients with atrial
fibrillation: a meta-analysis and systematic review // Int. J. Cardiol.
2016. Vol. 222. P. 289-294.
Zhuang X.-D., Long M., Li F., Hu X. et al. PDE5 inhibitor sildenafil in the treatment of heart failure: a
meta-analysis of randomized controlled trials // Int. J. Cardiol.
2014. Vol. 172, N. 3. P. 581-587.
Ziff O.J., Lane D.A., Samra M. et al. Safety and efficacy of digoxin: systematic review and meta-analysis
of observational and controlled trial data // BMJ. 2015.
Источник KingMed.info
396
Vol. 351. Article ID h4451.
Zimbron J., Khandaker G.M., Toschi C. et al. A systematic review and meta-analysis of randomised
controlled trials of treatments for clozapine-induced obesity and metabolic syndrome // Eur.
Neuropsychopharmacol. 2016. Vol. 26, N. 9. P. 1353-1365.